Sin-Ting Tiffany Lai, Mya Bojarsky, Julia Baran, Amber Isaza, Lindsay Sisko, Stephanie Gonzales, Brianna Spatz, Tricia Bhatti, Lea F Surrey, Zubair W Baloch, N Scott Adzick, Ken Kazahaya, Sogol Mostoufi-Moab, Andrew Bauer
{"title":"pT1a Papillary Thyroid Carcinomas in Pediatric Patients.","authors":"Sin-Ting Tiffany Lai, Mya Bojarsky, Julia Baran, Amber Isaza, Lindsay Sisko, Stephanie Gonzales, Brianna Spatz, Tricia Bhatti, Lea F Surrey, Zubair W Baloch, N Scott Adzick, Ken Kazahaya, Sogol Mostoufi-Moab, Andrew Bauer","doi":"10.1530/ETJ-25-0119","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Observational studies in adults suggest that incidental PTC (iPTC) and non-incidental PTC (niPTC) are distinct entities. We examine the incidence of iPTC in pediatric patients undergoing thyroidectomy for benign conditions and compare clinical and histopathologic findings, as well as outcomes, of iPTC with those of niPTC.</p><p><strong>Methods: </strong>A retrospective chart review was conducted at the Children's Hospital of Philadelphia between August 2010 and February 2023 to identify pediatric patients who underwent thyroidectomy and were diagnosed with pT1a PTC.</p><p><strong>Results: </strong>iPTC was identified in 23 of 453 (5.1%) patients undergoing thyroidectomy for benign conditions. Within a cohort of 66 patients diagnosed with pT1a PTC, 23 (34.8%) were classified as iPTC, and 43 (65.2%) were classified as niPTC. Compared to niPTC, iPTC had a significantly smaller median greatest dimension (iPTC: 3 mm, niPTC: 7 mm, p < 0.001), a lower rate of lymphatic invasion (iPTC: 0%, niPTC: 60.5%, p < 0.001), and AJCC N1 disease (iPTC: 0%, niPTC: 55.8%, p < 0.001). Most iPTC (22 out of 23 [95.7%]) were classified as ATA pediatric low-risk, while 6 out of 43 (14.0%) niPTC were categorized as intermediate/high-risk. Patients with iPTC and niPTC were followed for a median of 3.3 and 5.7 years, respectively. There was no evidence of persistent or recurrent disease in any patient with iPTC during this time frame.</p><p><strong>Conclusions: </strong>iPTC may be found in 5.1% of pediatric patients undergoing thyroidectomy for benign conditions. Similar to adults, iPTC in pediatric patients appears to be indolent with a minimal risk for invasive features and a low risk for persistent or recurrent disease. In contrast to iPTC, niPTC exhibits the potential for invasive behavior and should be regarded as a distinct entity.</p>","PeriodicalId":12159,"journal":{"name":"European Thyroid Journal","volume":" ","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Thyroid Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1530/ETJ-25-0119","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Observational studies in adults suggest that incidental PTC (iPTC) and non-incidental PTC (niPTC) are distinct entities. We examine the incidence of iPTC in pediatric patients undergoing thyroidectomy for benign conditions and compare clinical and histopathologic findings, as well as outcomes, of iPTC with those of niPTC.
Methods: A retrospective chart review was conducted at the Children's Hospital of Philadelphia between August 2010 and February 2023 to identify pediatric patients who underwent thyroidectomy and were diagnosed with pT1a PTC.
Results: iPTC was identified in 23 of 453 (5.1%) patients undergoing thyroidectomy for benign conditions. Within a cohort of 66 patients diagnosed with pT1a PTC, 23 (34.8%) were classified as iPTC, and 43 (65.2%) were classified as niPTC. Compared to niPTC, iPTC had a significantly smaller median greatest dimension (iPTC: 3 mm, niPTC: 7 mm, p < 0.001), a lower rate of lymphatic invasion (iPTC: 0%, niPTC: 60.5%, p < 0.001), and AJCC N1 disease (iPTC: 0%, niPTC: 55.8%, p < 0.001). Most iPTC (22 out of 23 [95.7%]) were classified as ATA pediatric low-risk, while 6 out of 43 (14.0%) niPTC were categorized as intermediate/high-risk. Patients with iPTC and niPTC were followed for a median of 3.3 and 5.7 years, respectively. There was no evidence of persistent or recurrent disease in any patient with iPTC during this time frame.
Conclusions: iPTC may be found in 5.1% of pediatric patients undergoing thyroidectomy for benign conditions. Similar to adults, iPTC in pediatric patients appears to be indolent with a minimal risk for invasive features and a low risk for persistent or recurrent disease. In contrast to iPTC, niPTC exhibits the potential for invasive behavior and should be regarded as a distinct entity.
期刊介绍:
The ''European Thyroid Journal'' publishes papers reporting original research in basic, translational and clinical thyroidology. Original contributions cover all aspects of the field, from molecular and cellular biology to immunology and biochemistry, from physiology to pathology, and from pediatric to adult thyroid diseases with a special focus on thyroid cancer. Readers also benefit from reviews by noted experts, which highlight especially active areas of current research. The journal will further publish formal guidelines in the field, produced and endorsed by the European Thyroid Association.